ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orr, M. D.
Right arrow Articles by Maresh, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orr, M. D.
Right arrow Articles by Maresh, J. G.

Ann Thorac Surg 1994;57:1007-1011
© 1994 The Society of Thoracic Surgeons


Articles

Removal of avitene microfibrillar collagen hemostat by use of suitable transfusion filters

Malcolm D. Orr, MD, PhDa,b, Ariel G. Ferdman, PhD*,a,b, J.Gregory Maresh, MChEa,b

a Department of Anesthesiology, University of Texas Health Science Center, San Antonio, Texas, USA
b Department of Anesthesiology, MedChem Products, Inc, Woburn, Massachusetts, USA

Accepted for publication September 30, 1993.

* Address reprint requests to Dr Ferdman, MedChem Products, Inc. 232 W Cummings Park, Woburn, MA 01801.

We assessed the ability of two commercial filters (Pall RC100 and Statlabs 20 µm) to filter out Avitene microfibrillar collagen hemostat from suspension. Quantitative determination of the collagen content as well as scanning election and light microscopy, particle counting, and platelet aggregometry of filtrates revealed that these filters effectively remove potentially thrombogenic particles of Avitene microfibrillar collagen hemostat. The filters removed at least 97% of the total collagen, as determined by hydroxyproline analysis. The collagen that passed through the Pall filter did not pellet upon ultracentrifugation. Scanning electron and light microscopic analysis revealed no Avitene microfibrillar collagen hemostat particulates in the Pall filtrates but did reveal the presence of a significant number of approximately 1- to 8-µm particulates in the Statlabs filtrates. Concentrates of the filtrates from either of the two filters, however, did not promote platelet aggregation. Through ultracentrifugation and infrared analysis, the filtrates were found to consist of soluble, partially denatured collagen. The risk associated with the reintroduction of collagen particulates into the vasculature can be significantly reduced by use of appropriate, currently available blood-transfusion filters.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Sirlak
Reply to the Editor
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1228 - 1228.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. J. Gu, A. J. deVries, P. W. Boonstra, and W. van Oeveren
LEUKOCYTE DEPLETION RESULTS IN IMPROVED LUNG FUNCTION AND REDUCED INFLAMMATORY RESPONSE AFTER CARDIAC SURGERY
J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 494 - 500.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.